Evidence map›Paper›PMID 42447122›Full record

ArticleHLA2026

Confirmation and Extension of the HLA-C*07:262 Allele.

Haoqiang Ding, Huaqin Liang, Xiuzhang Xu, Jing Liu, Xin Ye

Abstract read
In one paragraph

Article in HLA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haoqiang DingThe Key Medical Laboratory of Guangzhou, Institute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.ORCID https://orcid.org/0000-0002-0532-2119
Huaqin LiangThe Key Medical Laboratory of Guangzhou, Institute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.
Xiuzhang XuThe Key Medical Laboratory of Guangzhou, Institute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.
Jing LiuThe Key Medical Laboratory of Guangzhou, Institute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.ORCID https://orcid.org/0000-0001-7356-2029
Xin YeThe Key Medical Laboratory of Guangzhou, Institute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.

Funding

the Key Medical Disciplines Program of Guangzhou (2025-2027)the Science and Technology Project of Guangzhou 2024A03J0374the Science and Technology Project of Guangzhou 2024A03J0375the Science and Technology Project of Guangzhou 2025A03J3369
6 · The paper itself

Abstract

Confirmation of HLA-C*07:262 by third-generation sequencing, differing from C*07:02:01:01 by a single nucleotide substitution in exon 2.

Indexed as

AllelesExonsHLA-C AntigensPolymorphism, Single NucleotideBase SequenceCodonHigh-Throughput Nucleotide SequencingHistocompatibility TestingHumansPolymerase Chain ReactionSequence AlignmentSequence Analysis, DNATissue DonorsCodonHLA-C Antigensallele confirmationHLA‐C*07:262IPD‐IMGT/HLA databasePacBio sequencingthird‐generation sequencing

Identifiers

PMID42447122
PMCPMC13367601

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.